C19H25BN4O4
Neat
384.24
-20°C
Room Temperature
1132709-16-0; K6NMW4QRP5; Bortezomib, (1S, 2R)-; RefChem:1080111; (1S, 2R)-Bortezomib; ((S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid; [(1S)-3-methyl-1-[[(2R)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid; CHEMBL1530; Boronic acid, B-[(1S)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)aMino]propyl]aMino]butyl]-; B-[(1S)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic Acid; [(1S)-3-methyl-1-[(2R)-3-phenyl-2-[(pyrazin-2-yl)formamido]propanamido]butyl]boronic acid; Bortezomib Impurity (R and S-Isomer); NCGC00168751-01; Bortezomib Impurity 5; SCHEMBL3676; SCHEMBL30316729; GXJABQQUPOEUTA-NVXWUHKLSA-N; AC-819; BDBM50571513; EBC-29030
[(1S)-3-methyl-1-[[(2R)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid
InChI=1S/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)/t15-,17-/m1/s1